The DOI matches its Crossref record; 425 of the 425 references it cites were found in a registry or an index.
Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology
Abstract
Classically, polyunsaturated fatty acids (PUFA) were largely thought to be relatively inert structural components of brain, largely important for the formation of cellular membranes. Over the past 10 years, a host of bioactive lipid mediators that are enzymatically derived from arachidonic acid, the main n-6 PUFA, and docosahexaenoic acid, the main n-3 PUFA in the brain, known to regulate peripheral immune function, have been detected in the brain and shown to regulate microglia activation. Recent advances have focused on how PUFA regulate the molecular signaling of microglia, especially in the context of neuroinflammation and behavior. Several active drugs regulate brain lipid signaling and provide proof of concept for targeting the brain. Because brain lipid metabolism relies on a complex integration of diet, peripheral metabolism, including the liver and blood, which supply the brain with PUFAs that can be altered by genetics, sex, and aging, there are many pathways that can be disrupted, leading to altered brain lipid homeostasis. Brain lipid signaling pathways are altered in neurologic disorders and may be viable targets for the development of novel therapeutics. In this study, we discuss in particular how n-3 PUFAs and their metabolites regulate microglia phenotype and function to exert their anti-inflammatory and proresolving activities in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, low levels of blood n-3 PUFA correlate with heightened inflammatory status and depression risk in humans, whereas imposed dietary n-3 deficiency in rodents diminishes brain n-3 levels and stimulates neuroinflammation and anxiety-and depressive-like behaviors [47].”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [47]
In the citing paper
“In contrast, low levels of blood n-3 PUFA correlate with heightened inflammatory status and depression risk in humans, whereas imposed dietary n-3 deficiency in rodents diminishes brain n-3 levels and stimulates neuroinflammation and anxiety-and depressive-like behaviors [47].”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [47]
In the citing paper
“Several reports link higher n-3 consumption with lower prevalence and severity of mood disturbances in humans [45] and demonstrate that n-3 supplementation dampens neuroinflammation and attenuates behavioral indices of mood deficits in rodents [46,47].”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [47]
Citations
Cites
3 retracted
Items 401–425 of 425
Magnusardottir, A. R., Steingrímsdóttir, L., Þorgeirsdóttir, H., Gunnlaugsson, G., & Skúladóttir, G. V. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.10.004 · Cited by 30
Eady, T. N., Khoutorova, L., Atkins, K. D., Bazan, N. G., & Belayev, L. (2012) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-4-19 · Cited by 30
Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice
Boudrault, C., Bazinet, R. P., Kang, J. X., & David, W. L. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2009.12.022 · Cited by 29
Self-citationDifferences in long chain polyunsaturates composition and metabolism in male and female rats
Lin, Y., Brown, J. A., DiMartino, C., Dahms, I., Salem, N., & Hibbeln, J. R. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.08.008 · Cited by 29
Park, S., Hah, J. H., Oh, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2499-3 · Cited by 28
Hu, Y., Sun, H., O’Flaherty, J. T., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs324 · Cited by 27
Larrieu, T., Hilal, M. L., Smedt, V. D., Sans, N., & Layé, S. (2015) · Neural Plasticity · doi:10.1155/2016/8574830 · Cited by 27
Self-citation(1995) · Neurology · doi:10.1212/wnl.45.2.6a · Cited by 27
Fatty Aspirin: A New Perspective in the Prevention of Dementia of Alzheimers Type?
Pomponi, M., Gioia, A. D., Bria, P., & Pomponi, M. F. L. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908892 · Cited by 26
McNamara, R. K., Able, J. A., Jandacek, R. J., et al. (2008) · Lipids · doi:10.1007/s11745-008-3244-8 · Cited by 25
Muntané, G., Janué, A., Fernandez, N., Odena, M. A., de Oliveira, E., Boluda, S., Portero‐Otín, M., Naudí, A., Boada, J., Pamplona, R., et al. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.10.015 · Cited by 24
Gender-specific fatty acid profiles in platelet phosphatidyl-choline and -ethanolamine
Geppert, J., Min, Y., Neville, M., Lowy, C., & Ghebremeskel, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.09.002 · Cited by 23
Manzhulo, I., Ogurtsova, O. S., Lamash, N. E., Latyshev, N. A., Kasyanov, S. P., & Dyuizen, I. V. (2015) · Acta Histochemica · doi:10.1016/j.acthis.2015.07.001 · Cited by 23
Dinel, A., Rey, C., Baudry, C., Fressange-Mazda, C., Ruyet, P. L., Nadjar, A., Pallet, P., Joffre, C., & Layé, S. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.08.013 · Cited by 23
Self-citationRetinal Microglial Activation and Chemotaxis by Docosahexaenoic Acid Hydroperoxide
Saraswathy, S., Wu, G., & Rao, N. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0221 · Cited by 22
Huang, C.-T., & Tsai, Y.-J. (2016) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.009 · Cited by 22
Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids
McNamara, R. K. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2015.1080527 · Cited by 21
Zulyniak, M. A., Roke, K., Gerling, C., Logan, S. L., Spriet, L. L., & Mutch, D. M. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500830 · Cited by 21
Lopes, L. T., Baldy, C., Jochmans‐Lemoine, A., Mercier, O., Pothier‐Piccinin, O., Seaborn, T., Joseph, V., Marc, I., & Kinkead, R. (2016) · The Journal of Physiology · doi:10.1113/jp273471 · Cited by 21
Grundy, T., Toben, C. G., Jaehne, E. J., Corrigan, F., & Baune, B. T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00399 · Cited by 20
Regulation of 15-lipoxygenase expression by cytokines.
Brinckmann, R., & Kühn, H. (1997) · PubMed · Cited by 19
Rôle de la réponse immunitaire innée dans le cerveau
Blais, V., & Rivest, S. (2003) · médecine/sciences · doi:10.1051/medsci/20031910981 · Cited by 16
Mirza, M., Volz, C., Karlstetter, M., Langiu, M., Somogyi, A., Ruonala, M. O., Tamm, E. R., Jägle, H., & Langmann, T. (2013) · PLoS ONE · doi:10.1371/annotation/ae907882-62e0-4803-8c00-35b30a649fe9 · Cited by 15
Pomponi, M. F. L., Gambassi, G., Pomponi, M., Gioia, A. D., & Masullo, C. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.09.003 · Cited by 13
Zarghi, A. (2015) · Scientia Pharmaceutica · doi:10.3797/scipharm.1407-20 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 1
- Malvy, 1999, La consommation de lipides en France: contribution à l’équilibre nutritionnel (données préliminaires de l’étude SU.VI.MAX), Ol Corps Gras Lipides, 6, 21
Cited by
Sorted by citations
The menace of obesity to depression and anxiety prevalence
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.10.005 · Cited by 441
“In contrast, low levels of blood n-3 PUFA correlate with heightened inflammatory status and depression risk in humans, whereas imposed dietary n-3 deficiency in rodents diminishes brain n-3 levels and stimulates neuroinflammation and anxiety- and depressive-like behaviors [47].”
BackgroundHealth benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Zhang, T.-T., Xu, J., Wang, Y.-M., & Xue, C.-H. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.100997 · Cited by 339
Lipid and Lipoprotein Metabolism in Microglia
Loving, B. A., & Bruce, K. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00393 · Cited by 255
Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system
Yang, S., Qin, C., Hu, Z.-W., Zhou, L.-Q., Yu, H.-H., Chen, M., Bosco, D. B., Wang, W., Wu, L.-J., & Tian, D.-S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105290 · Cited by 232
Desale, S. E., & Chinnathambi, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00715-0 · Cited by 81
Metadata
- Authors
- Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P.
- Affiliations
- Université de Bordeaux (FR)
- University of Toronto (CA)
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 70
- Issue
- 1
- Pages
- 12-38
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2775574923
- Cited by
- 420
- References
- 425
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 36 · 2023: 43 · 2022: 56 · 2021: 64 · 2020: 66 · 2019: 43 · 2018: 24
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Reviews (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- omega-3 fatty acids, docosahexaenoic acid, polyunsaturated fatty acids, microglial activation, neuroinflammation, eicosanoids, arachidonic acid metabolites, specialized pro-resolving mediators, neurological disorders, anti-inflammatory activity, microglial phenotype
- MeSH terms
- Animals, Anti-Inflammatory Agents, Brain, Humans, Fatty Acids, Omega-3, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
